The Bandim Health Project, run by Danish researchers Peter Aaby and Christine Stabell Benn, has operated in Guinea-Bissau for decades and is closely enmeshed in the country’s health system. At least one top official, the current director of public health, held a
dual appointment with Bandim as recently as December.
Kennedy praised the Danish researchers at a recent anti-vaccine conference, calling them “the deities of vaccine research”. Kennedy claimed that a prior study they conducted indicated that after vaccination, “you can have mass injuries, and catastrophic injuries, and they’re hiding in plain sight.” He did not mention that another follow-up study from the same researchers
found no effects at all.
This study will focus on vaccination and mortality, as well as outcomes such as skin conditions and neurodevelopmental conditions. “The main problem of this trial is that you have some very well-known bad diseases that you can protect with this vaccine,” Støvring said. “And what they then want to study is something highly speculative – in a situation where WHO and others are saying that you should give this vaccine at birth, period.”
When asked about the study in a Thursday briefing, an official with the Africa CDC, which has opposed the trial, said there were “ongoing discussions” between the US and Guinea-Bissau and more details would be shared shortly. Guinea-Bissau planned to begin vaccinating all newborns against hepatitis B in 2027, but they pushed the campaign back to 2028.